Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (unspecified eye)
ICD-10 E10.3419 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (unspecified eye).
E10.3419 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by severe nonproliferative diabetic retinopathy (NPDR) and macular edema in an unspecified eye. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to chronic hyperglycemia. Severe NPDR is marked by significant retinal changes, including extensive retinal hemorrhages, cotton wool spots, and the presence of macular edema, which can lead to vision impairment. Macular edema occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. The management of this condition often involves strict glycemic control, regular ophthalmologic evaluations, and potential interventions such as laser therapy or intravitreal injections to address the edema. Monitoring HbA1c levels is crucial, as maintaining them below 7% can help prevent or slow the progression of diabetic complications.
Detailed records of diabetes management, including HbA1c levels and treatment plans.
Patients presenting with uncontrolled diabetes and complications.
Ensure comprehensive documentation of diabetes management and referrals to ophthalmology.
Thorough retinal examination findings, including descriptions of NPDR and macular edema.
Patients with diabetes presenting for routine eye exams or vision changes.
Document the severity of retinopathy and any interventions performed.
Used for treating macular edema in patients with severe NPDR.
Document the indication for laser treatment and the extent of the procedure.
Ophthalmologists should ensure that the diagnosis aligns with the procedure performed.
Documenting HbA1c levels is crucial as it reflects the patient's long-term glycemic control and helps in assessing the risk of diabetic complications, including retinopathy.
Nonproliferative diabetic retinopathy is characterized by retinal hemorrhages and exudates without new blood vessel growth, while proliferative diabetic retinopathy involves the growth of new, abnormal blood vessels on the retina.
